| A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors (NCT03872947) | Toray Industries, Inc | 2019-04-26 |
| Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143 (NCT04122625) | Debiopharm International SA | 2019-04-26 |
| Single-dose/Multiple-doses Incremental Intravenous Injection of SY-005 （Recombinant Human Annexin A5）in Healthy Subjects (NCT04217629) | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | 2019-04-26 |
| Safety, Tolerability, Pharmacokinetics, and Anti-Retroviral Activity of MK-8558 Monotherapy in Anti-Retroviral-Naïve HIV-1 Infected Participants (MK-8558-002) (NCT03859739) | Merck Sharp & Dohme LLC | 2019-04-26 |
| Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor (NCT03985072) | Andes Biotechnologies | 2019-04-26 |
| Generation of Biological Samples Positive to Triptorelin for Anti-doping Control (NCT04189900) | Parc de Salut Mar | 2019-04-26 |
| An Ascending Dose Comparison of MVT-100 to Definity in Healthy Volunteers (NCT03882359) | Microvascular Therapeutics, LLC | 2019-04-25 |
| : A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid Tumors (NCT03903705) | Hutchmed | 2019-04-25 |
| Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, LS1681 Trial (NCT03003546) | Mayo Clinic | 2019-04-25 |
| Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives (NCT03954366) | pharmaand GmbH | 2019-04-25 |
| First-in-human Study to Assess Safety and Tolerability of a Single Subcutaneous Dose of SAR441255 in Lean to Overweight Subjects (NCT04521738) | Sanofi | 2019-04-25 |
| BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients (NCT03943940) | Van Hanh General Hospital | 2019-04-24 |
| Phase 1 Study of ATR-002 (NCT04385420) | Atriva Therapeutics GmbH | 2019-04-24 |
| Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan® (NCT03965052) | Laboratorios Sophia S.A de C.V. | 2019-04-24 |
| The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects (NCT03734302) | Otsuka Beijing Research Institute | 2019-04-24 |
| GB004 in Adult Subjects With Active Ulcerative Colitis (NCT03860896) | GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 2019-04-24 |
| A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis (NCT03542994) | Evelo Biosciences, Inc. | 2019-04-24 |
| C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) (NCT03635632) | Baylor College of Medicine | 2019-04-23 |
| PK/PD Biosimilarity Study of Gan & Lee Insulin Lispro Injection vs. EU and US Humalog® in Healthy Males (NCT04235439) | Gan and Lee Pharmaceuticals, USA | 2019-04-23 |
| CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma (NCT03710421) | City of Hope Medical Center | 2019-04-23 |
| HeartPhone Cancer Survivors Trial 2019 (NCT03953326) | Penn State University | 2019-04-23 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis (NCT03960450) | Boston Pharmaceuticals | 2019-04-23 |
| A Study in Healthy Men That Tests if Taking BI 1265162 by Mouth, Intravenously, or Inhaled Influences the Amount of BI 1265162 in the Blood (NCT03907280) | Boehringer Ingelheim | 2019-04-23 |
| Study to Characterize Absorption, Distribution, Metabolism and Excretion of 14C PF-06651600 and to Evaluate the Absolute Oral Bioavailability and Fraction Absorbed of PF-06651600. (NCT03929510) | Pfizer | 2019-04-23 |
| A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma (NCT03825705) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-04-23 |
| Evaluate the Safety Pharmacokinetics of a Human Monoclonal Antibody S315 Against Diphtheria Toxin in Healthy Subjects (NCT04075175) | MassBiologics | 2019-04-23 |
| A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers (NCT04324424) | Hua Medicine Limited | 2019-04-23 |
| To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers (NCT04150172) | Korea Otsuka Pharmaceutical Co., Ltd. | 2019-04-22 |
| Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC (NCT03838367) | CytoDyn, Inc. | 2019-04-22 |
| A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia (NCT03806556) | Meghan McCormick | 2019-04-22 |
| Fluorescence QRH-882260 Peptide Imaging in the Bile Duct (NCT03438435) | D. Kim Turgeon, MD | 2019-04-22 |
| Study Assessing Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MGTA-145 in Healthy Volunteers as a Single Agent or in Combination With Plerixafor (NCT03932864) | Ensoma | 2019-04-22 |
| A Multicenter Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery Recurrence (NCT03945799) | Zhejiang University | 2019-04-22 |
| Doravirine, Rifapentine and Isoniazid Interaction (NCT03886701) | Walter K. Kraft | 2019-04-22 |
| A Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants (NCT03922633) | EA Pharma Co., Ltd. | 2019-04-22 |
| Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers (NCT04337437) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2019-04-22 |
| A PK Study of Oraxol in Breast Cancer Patients (NCT04993040) | Athenex, Inc. | 2019-04-22 |
| Study to Assess Safety and Ability to Induce Immune Responses of HIV-1 Vaccines M3 and M4 Given Alone or in Combination in HIV-infected Adults (NCT03844386) | University of North Carolina, Chapel Hill | 2019-04-22 |
| HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis (NCT03934736) | Dynavax Technologies Corporation | 2019-04-22 |
| Mood Effects of Serotonin Agonists Extended (NCT03934710) | University of Chicago | 2019-04-20 |
| MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer (NCT03916679) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2019-04-20 |
| Pentoxifylline Add-on Therapy for Schizophrenia (NCT05073640) | Mazra Mental Health Center | 2019-04-20 |
| The Optimal Dose of Mannitol for Intraoperative Brain Relaxation During the Operation of Aneurysmal Subarachnoid Hemorrhage (NCT04135456) | Beijing Tiantan Hospital | 2019-04-20 |
| TCR-Redirected T Cells Therapy in Patient With HBV Related HCC (NCT03899415) | Beijing 302 Hospital | 2019-04-20 |
| Study of IBI318 in Participants With Advanced Malignancies (NCT03875157) | Innovent Biologics (Suzhou) Co. Ltd. | 2019-04-19 |
| IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer (NCT03918499) | City of Hope Medical Center | 2019-04-19 |
| Combined Focused Ultrasound and Calcium Hydroxylapatitie Filler for Skin Laxity and Volume Restoration (NCT04176068) | University of California, Irvine | 2019-04-19 |
| A Proof-of-Concept Study of Minocycline in Autism (NCT04031755) | Children's Hospital Medical Center, Cincinnati | 2019-04-19 |
| Investigating Immune Responses to Aerosol BCG Challenge in Healthy UK Adults (NCT03912207) | University of Oxford | 2019-04-19 |
| Safety and Efficacy Study of ATGC-100 for the Treatment of Moderate to Severe Glabellar Lines in Adult Subjects (NCT03970876) | EuBiologics Co.,Ltd | 2019-04-19 |
| D-0120 Safety and PK/PD Study in China (NCT03923868) | InventisBio Co., Ltd | 2019-04-18 |
| A Study in Healthy Men to Test Whether BI 1358894 Reduces Druginduced Panic Symptoms (NCT03904576) | Boehringer Ingelheim | 2019-04-18 |
| CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant (NCT03922035) | City of Hope Medical Center | 2019-04-18 |
| THE EFFECT OF MULTIPLE DOSES OF PF-06835919 ON THE PHARMACOKINETICS OF A SINGLE ORAL MIDAZOLAM DOSE IN HEALTHY PARTICIPANTS (NCT03916406) | Pfizer | 2019-04-18 |
| Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia (NCT03760523) | H. Lee Moffitt Cancer Center and Research Institute | 2019-04-18 |
| ASSIST: Treatment for Childhood Apraxia of Speech (NCT03903120) | Temple University | 2019-04-18 |
| Drug Interaction Study Between Dorzagliatin and Empagliflozin (NCT03790787) | Hua Medicine Limited | 2019-04-18 |
| Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer (NCT03591276) | Shaare Zedek Medical Center | 2019-04-18 |
| Nutritional Strategies for Metabolic Health in Aging (NCT04282603) | University of Alaska Fairbanks | 2019-04-18 |
| TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer (NCT03964532) | Georgetown University | 2019-04-17 |
| Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma (NCT03829020) | Mayo Clinic | 2019-04-17 |
| Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B (NCT03882437) | Rocket Pharmaceuticals Inc. | 2019-04-17 |
| Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis (NCT04176224) | Shionogi | 2019-04-17 |
| Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male Subjects (NCT03882112) | Hanmi Pharmaceutical Company Limited | 2019-04-17 |
| Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke (NCT03384433) | Isfahan University of Medical Sciences | 2019-04-17 |
| A Study to Learn More About the Safety and the Level of BAY 1747846 in Body Given as Injection Into the Vein at Increasing Single Doses in Japanese Healthy Male Participants (NCT06125366) | Bayer | 2019-04-17 |
| Safety and Pharmacokinetics of ODM-209 (NCT03878823) | Orion Corporation, Orion Pharma | 2019-04-17 |
| Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma (NCT03778073) | TG Therapeutics, Inc. | 2019-04-17 |
| Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia (NCT03672851) | Second Affiliated Hospital of Xi'an Jiaotong University | 2019-04-17 |
| Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3) (NCT03792516) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-04-17 |
| Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers (NCT03878121) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-04-17 |
| Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers (NCT03911973) | Kari Wisinski | 2019-04-17 |
| Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors (NCT03875287) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-04-17 |
| Study of TP-3654 in Patients With Advanced Solid Tumors (NCT03715504) | Sumitomo Pharma America, Inc. | 2019-04-16 |
| A Study of Safety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary Fibrosis (NCT03949530) | Indalo Therapeutics, Inc. | 2019-04-16 |
| Study of MAX-40279 in Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML) (NCT04187495) | Maxinovel Pty., Ltd. | 2019-04-16 |
| A Pharmacokinetic and Bioequivalence Study of Savolitinib Tablets in Healthy Chinese Male Volunteers (NCT03860948) | Hutchison Medipharma Limited | 2019-04-16 |
| Vitamin D Metabolism in Patients With Endocrine Disorders (NCT04844164) | Endocrinology Research Centre, Moscow | 2019-04-16 |
| Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma (NCT03934814) | I-Mab Biopharma US Limited | 2019-04-16 |
| A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours (NCT03990233) | OSE Immunotherapeutics | 2019-04-16 |
| Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma (NCT03922880) | Memorial Sloan Kettering Cancer Center | 2019-04-16 |
| Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) (NCT03897036) | Senhwa Biosciences, Inc. | 2019-04-16 |
| Leflunomide in Previously Treated Metastatic Triple Negative Cancers (NCT03709446) | Joseph Sparano | 2019-04-16 |
| Study of HPN536 in Patients With Advanced Cancers Associated With Mesothelin Expression (NCT03872206) | Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2019-04-16 |
| Dietary Intervention in Patients with a History of Melanoma (NCT03950635) | M.D. Anderson Cancer Center | 2019-04-16 |
| A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants (NCT05630274) | Eli Lilly and Company | 2019-04-16 |
| A Gene Therapy Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I (NCT03825783) | Rocket Pharmaceuticals Inc. | 2019-04-15 |
| Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy (NCT04082000) | Breath of Life International Pharma Ltd | 2019-04-15 |
| A Dose Escalation Study of IBI302 in Patients With Wet Age-related Macular Degeneration (NCT03814291) | Innovent Biologics (Suzhou) Co. Ltd. | 2019-04-15 |
| PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC (NCT03829007) | Radboud University Medical Center | 2019-04-15 |
| Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis. (NCT03898583) | LEO Pharma | 2019-04-15 |
| Fecal Microbial Transplant (FMT) for Sjogrens Syndrome (NCT03926286) | University of Miami | 2019-04-15 |
| Effect of Meal Composition and Timing on Evobrutinib Bioavailability (NCT03934502) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2019-04-15 |
| A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors (NCT03967093) | Bexion Pharmaceuticals, Inc. | 2019-04-15 |
| A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor (NCT03802084) | Hyo Song Kim | 2019-04-15 |
| Comparison of Safety, Tolerability and Pharmacokinetics of Medical Grade Cannabis (MGC) Orally Disintegrating Tablets With Buccal Sativex®, in Healthy Adult Volunteers (NCT03936907) | One World Cannabis Ltd. | 2019-04-15 |
| A Study of JNJ-64530440 in Healthy Japanese Male Participants (NCT03915886) | Janssen Pharmaceutical K.K. | 2019-04-15 |
| A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers (NCT03821233) | Zymeworks BC Inc. | 2019-04-15 |
| PF-06651600 Taste Study. (NCT03916393) | Pfizer | 2019-04-15 |
| A Trial of SHR0410 Injection in Hemodialysis Participants. (NCT03857568) | Atridia Pty Ltd. | 2019-04-15 |